The BCL2 Selective Inhibitor Venetoclax Induces Rapid Onset Apoptosis of CLL Cells in Patients Via a TP53-independent Mechanism.
Mary Ann Anderson,Jing Deng,John F. Seymour,Constantine Tam,Su Young Kim,Joshua Fein,Lijian Yu,Jennifer R. Brown,David Westerman, Eric G. Si,Ian J. Majewski,David Segal,Sari L. Heitner Enschede,David C. S. Huang,Matthew S. Davids,Anthony Letai,Andrew W. Roberts Blood（2016）
AI 理解论文
溯源树
样例
